PROCTER & GAMBLE HEALTH | FDC | PROCTER & GAMBLE HEALTH/ FDC |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.7 | 25.4 | 136.6% | View Chart |
P/BV | x | 10.6 | 3.7 | 285.2% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH FDC |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
FDC Mar-23 |
PROCTER & GAMBLE HEALTH/ FDC |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 318 | 1,688.6% | |
Low | Rs | 3,883 | 229 | 1,694.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 107.5 | 689.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 11.7 | 1,183.2% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 14.0 | 1,106.0% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 119.5 | 374.7% | |
Shares outstanding (eoy) | m | 16.60 | 165.91 | 10.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.5 | 245.4% | |
Avg P/E ratio | x | 33.5 | 23.4 | 142.9% | |
P/CF ratio (eoy) | x | 29.8 | 19.5 | 152.9% | |
Price / Book Value ratio | x | 10.3 | 2.3 | 451.3% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 45,368 | 169.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 3,909 | 52.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 17,838 | 68.9% | |
Other income | Rs m | 184 | 512 | 35.9% | |
Total revenues | Rs m | 12,480 | 18,350 | 68.0% | |
Gross profit | Rs m | 3,247 | 2,496 | 130.1% | |
Depreciation | Rs m | 281 | 389 | 72.2% | |
Interest | Rs m | 8 | 41 | 18.8% | |
Profit before tax | Rs m | 3,142 | 2,578 | 121.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 640 | 132.4% | |
Profit after tax | Rs m | 2,295 | 1,938 | 118.4% | |
Gross profit margin | % | 26.4 | 14.0 | 188.7% | |
Effective tax rate | % | 27.0 | 24.8 | 108.7% | |
Net profit margin | % | 18.7 | 10.9 | 171.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 14,431 | 81.2% | |
Current liabilities | Rs m | 6,791 | 7,296 | 93.1% | |
Net working cap to sales | % | 40.0 | 40.0 | 100.1% | |
Current ratio | x | 1.7 | 2.0 | 87.2% | |
Inventory Days | Days | 263 | 265 | 99.2% | |
Debtors Days | Days | 343 | 251 | 136.9% | |
Net fixed assets | Rs m | 10,617 | 17,347 | 61.2% | |
Share capital | Rs m | 166 | 166 | 100.1% | |
"Free" reserves | Rs m | 7,265 | 19,655 | 37.0% | |
Net worth | Rs m | 7,431 | 19,820 | 37.5% | |
Long term debt | Rs m | 0 | 6 | 0.0% | |
Total assets | Rs m | 22,330 | 31,796 | 70.2% | |
Interest coverage | x | 409.1 | 64.1 | 638.4% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 98.2% | |
Return on assets | % | 10.3 | 6.2 | 165.6% | |
Return on equity | % | 30.9 | 9.8 | 315.8% | |
Return on capital | % | 42.4 | 13.2 | 320.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 8.5 | 154.3% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | 1,509 | 106.4% | |
Fx inflow | Rs m | 1,465 | 3,259 | 45.0% | |
Fx outflow | Rs m | 1,605 | 1,509 | 106.4% | |
Net fx | Rs m | -140 | 1,749 | -8.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 1,549 | 152.3% | |
From Investments | Rs m | -215 | 111 | -193.1% | |
From Financial Activity | Rs m | -985 | -1,800 | 54.7% | |
Net Cashflow | Rs m | 1,160 | -138 | -838.4% |
Indian Promoters | % | 0.0 | 69.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 9.6 | 208.2% | |
FIIs | % | 6.2 | 2.7 | 235.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 30.3 | 158.8% | |
Shareholders | 56,778 | 52,377 | 108.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | FDC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.51% | 1.51% | 1.03% |
1-Month | -0.93% | 7.14% | 1.10% |
1-Year | 0.82% | 50.36% | 53.75% |
3-Year CAGR | -8.69% | 13.72% | 14.67% |
5-Year CAGR | 4.87% | 22.46% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the FDC share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of FDC the stake stands at 69.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of FDC.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
FDC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of FDC.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.